Abstract:The development of injectable integrin alpha(v)beta(3)/alpha(IIb)beta(3) dual antagonists attracts much attention of research for treating of acute ischemic diseases in recent years. In this work, based on a dataset composed of 102 tricyclic piperazine/piperidine furnished dual alpha(v)beta(3) and alpha(IIb)beta(3) antagonists, a variety of in silico modeling approaches including the comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), and molecular docking were applied to reveal the requisite 3D structural features impacting the biological activities. Our statistical results show that the ligand-based 3D-QSAR models for both the alpha(v)beta(3) and alpha(IIb)beta(3) studies exhibited satisfactory internal and external predictability, i.e., for the CoMFA models, results of Q(2) = 0.48, R-ncv(2) = 0.87, R-pred(2) = 0.71 for alpha(v)beta(3) and Q(2) = 0.50, R-ncv(2) = 0.85, R-pred(2) = 0.72 for alpha(IIb)beta(3) analysis were obtained, and for the CoMSIA ones, the outcomes of Q(2) = 0.55, R-ncv(2) = 0.90, R-pred(2) = 0.72 for alpha(v)beta(3) and Q(2) = 0.52, R-ncv(2) = 0.88, R-pred(2) = 0.74 for alpha(IIb)beta(3) were achieved respectively. In addition, through a comparison between 3D-QSAR contour maps and docking results, it is revealed that that the most crucial interactions occurring between the tricyclic piperazine/piperidine derivatives and alpha(v)beta(3)/alpha(IIb)beta(3) receptor ligand binding pocket are H-bonding, and the key amino acids impacting the interactions are Arg214, Asn215, Ser123, and Lys253 for alpha(v)beta(3), but Arg214, Asn215, Ser123 and Tyr190 for alpha(IIb)beta(3) receptors, respectively. Halogen-containing groups at position 15 and 16, benzene sulfonamide substituent at position 23, and the replacement of piperazine with 4-aminopiperidine of ring B may increase the alpha(v)beta(3)/alpha(IIb)beta(3) antagonistic activity. The potencies for antagonists to inhibit isolated alpha(v)beta(3) and alpha(IIb)beta(3) are linear correlated, indicating that similar interaction mechanisms may exist for the series of molecules. To our best knowledge this is the first report on 3D-QSAR modeling of these dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. The results obtained should provide information for better understanding of the mechanism of antagonism and thus be helpful in design of novel potent dual alpha(v)beta(3)/alpha(IIb)beta(3) antagonists. (C) 2011 Elsevier Inc. All rights reserved.

Molecular modeling studies on the selectivity of 4-benzylpiperidine antagonists for hCCR3

Studies of H4R Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Studies of Tricyclic Piperazine/piperidine Furnished Molecules As Novel Integrin Αvβ3/αiibβ3 Dual Antagonists Using 3D-QSAR and Molecular Docking.

Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.

Computational Studies of the Binding Modes of Ccr1 Antagonists

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives As Α1a-Adrenoceptor Antagonists

Insights into binding modes of 5-HT2c receptor antagonists with ligand-based and receptor-based methods

Pharmacophore Modeling of Dual Angiotensin II and Endothelin A Receptor Antagonists.

In Silico Binding Characteristics Between Human Histamine H-1 Receptor and Antagonists

Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.

3D-Pharmacophere Models for CC Chemokine Receptor 1 Antagonists.

Design, Syntheses, and Characterization of Piperazine Based Chemokine Receptor CCR5 Antagonists As Anti Prostate Cancer Agents.

The Synthesis of Substituted Bipiperidine Amide Compounds As CCR3 Ligands: Antagonists Versus Agonists.

Homology modeling and 3D-QSAR study of benzhydrylpiperazine δ opioid receptor agonists

Comparison of the Selectivity of Human Adenosine Receptor Antagonists Based on Structure and Pharmacophore Features

Design and Synthesis of Tri‐substituted Chiral Pyrrolidin‐2‐one Derivatives As CCR4 Antagonists

Computational Investigation on the Binding Modes of Rimonabant Analogs with CB1 and CB2

Docking and MD Study of Histamine H4R Based on the Crystal Structure of H1R

Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists

Studies of New Fused Benzazepine As Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

Hqsar and Topomer Comfa for Predicting Melanocortin-4 Receptor Binding Affinities of Trans-4-(4-Chlorophenyl) Pyrrolidine-3-Carboxamides